So this brings Harry's estimate down to $6-$10 per share or a sale amount of $35-60Billion. This sounds achievable given the Seagen deal, but we have not factored in the other platforms, only CF33.
Thanks Harry for your calculations. Is 5 times revenue normal and if IMUGENE drugs are cheaper to produce and buy (assuming they also drop the price) will the 15% market share be discounted for the drop in revenue for that 15%?
Thanks all.
IMU Price at posting:
10.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)